Sotera Health Company (SHC)
NASDAQ: SHC · IEX Real-Time Price · USD
+0.17 (1.39%)
At close: Jul 12, 2024, 4:00 PM
-0.09 (-0.73%)
After-hours: Jul 12, 2024, 6:44 PM EDT

Company Description

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally.

The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services.

It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries.

The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.

Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Sotera Health Company
Sotera Health Company logo
Country United States
IPO Date Nov 20, 2020
Industry Diagnostics & Research
Sector Healthcare
Employees 3,000
CEO Michael B. Petras Jr.

Contact Details

9100 South Hills Blvd, Suite 300
Broadview Heights, Ohio 44147
United States
Phone 440-262-1410

Stock Details

Ticker Symbol SHC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.00
CIK Code 0001822479
CUSIP Number 83601L102
ISIN Number US83601L1026
Employer ID 47-3531161
SIC Code 8090

Key Executives

Name Position
Michael B. Petras Jr. Chairman and Chief Executive Officer
Alexander Dimitrief Senior Vice President, General Counsel and Secretary
Michael P. Rutz President of Sterigenics
Jonathan M. Lyons Senior Vice President and Chief Financial Officer
Robert G. Hauzie Chief Information Officer
Kristin A. Gibbs Chief Marketing Officer
William O. Lehmann Jr., J.D., M.B.A. Senior Vice President of Strategy and Corporate Development
Sally R. Turner Chief Human Resources Officer
Kathleen A. Hoffman Senior Vice President of Global Environmental, Health and Safety
Joseph A. Shrawder President of Nelson Labs

Latest SEC Filings

Date Type Title
May 31, 2024 SD Form - SD
May 30, 2024 8-K Current Report
May 24, 2024 8-K Current Report
May 23, 2024 8-K Current Report
May 16, 2024 8-K Current Report
May 8, 2024 DEFR14A Filing
May 2, 2024 10-Q Quarterly Report
May 2, 2024 8-K/A [Amend] Current report
May 2, 2024 8-K Current Report
Apr 11, 2024 ARS Filing